Eric Hyllengren | VP of IR and Finance |
Pascal Touchon | President and CEO |
Utpal Koppikar | Chief Financial Officer |
Jakob Dupont | EVP and Global Head of Research and Development |
AJ Joshi | Chief Medical Officer |
Kristin Yarema | Chief Commercial Officer |
Salim Syed | Mizuho |
Tessa Romero | JPMorgan |
John Newman | Canaccord |
Marc Frahm | Cowen and Company |
Ben Burnett | Stifel |
Jonathan Miller | Evercore ISI |
Salveen Richter | Goldman Sachs |
Yigal Nochomovitz | Citigroup |
Tony Butler | ROTH Capital |
Good afternoon, everyone. Thank you for standing by, and welcome to the Atara Biotherapeutics’ First Quarter 2022 Financial Results Conference Call. [Operator Instructions] Please be advised that today's call is being recorded. I'd now like to hand the call over to Eric Hyllengren, Vice President of Investor Relations and Finance at Atara Biotherapeutics. Please proceed, sir.